CXCR4 and cancer: Other chemokines and receptors, such as CCL2 (Sandhu et al., 2013), CCR5 (Doi et al., 2019), and CXCR4 (Ghobrial et al., 2020), have also been used in combination with other drugs in a variety of cancers.